“Role of Intranasal Midazolam As a Procedural Sedative in Children Aged 6 Months to 12 Years: An Open-Label Randomized Controlled Study”. Indian Journal of Child Health, vol. 5, no. 1, Jan. 2018, pp. 1-5, https://doi.org/10.32677/IJCH.2018.v05.i01.001.